Analyst Matthew Luchini works at BMO and is covering the the Healthcare sector with 306 price targets and ratings documented since 2016 spanning on 23 stocks.
Matthew Luchini's average stock forecast success ratio is 46.01% with an average time for price targets to be met of 160.41 days.
Most recent stock forecast was given on GILD, Gilead Sciences, Inc at 16-May-2023.
Analyst best performing recommendations are on BLUE (BLUEBIRD BIO, INC).
The best stock recommendation documented was for BLUE (BLUEBIRD BIO, INC) at 2/24/2021. The price target of $20.08 was fulfilled within 2 days with a profit of $3.3 (19.67%) receiving and performance score of 98.33.
Average potential price target upside
Currently, out of the existing stock ratings of Matthew Luchini - 49 which are a Hold (36.84%), 84 which are a Buy (63.16%)
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average time for PT to be met
Performance score
Hold
0.4
$0.01 (2.56%)
7 months 16 days ago
2/2 (100%)
$0.51 (11.28%)
2
Buy
7 months 16 days ago
0/8 (0%)
$12.64 (79.14%)
Buy
12
7 months 17 days ago
0/4 (0%)
$10.17 (97.61%)
Buy
8 months 11 days ago
0/1 (0%)
$8.19 (140.96%)
Buy
11
8 months 12 days ago
0/2 (0%)
$8.27 (173.02%)
